It is believed that “SGF®” administered nasally acts on the neural system within the brain through the olfactory nerves. Currently, numerous clinical trials are underway with many hopefuls, awaiting further elucidation of the effects of “SGF®”.
Improvement of sequelae after cerebral infarction (motor dysfunction).
As a result of continuous intranasal administration of “SGF®” for motor dysfunction caused by sequelae of cerebral infarction, there are several cases where motor function has improved.
Improvement and prevention of dementia
There are cases where continuous nasal administration of “SGF®” has shown a tendency to improve dementia.
Measurement using the Revised Hasegawa Dementia Scale (HDS-R)
Expected Effects:
- Improved mental clarity (feeling refreshed)
- Improvement and prevention of dementia
- Prevention of stroke and improvement of motor dysfunction due to post-stroke sequelae
